Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

Coniagas Battery Metals Completes Private Placement

October 1, 2024

Altech Batteries Ltd$4M Placement to Advance Battery Projects

November 15, 2024

Crypto Market Update: Ethereum Rallies Past US$4,000, Trump...

August 9, 2025

Snow Lake Completes AMU Investment

September 9, 2025

Top 5 Canadian Mining Stocks This Week: Durango...

February 15, 2025

Awale Resources Limited

August 5, 2024

Top 5 Junior Copper Stocks on the TSXV...

July 20, 2024

Top 4 Largest Lithium Reserves by Country

March 7, 2025

Crypto Market Update: Trump Pardons Binance Founder, Wall...

October 25, 2025

India to Target Pacific Ocean for Deep-sea Critical...

July 24, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Israeli hostages freed, Iran hit, ceasefire held — 2025 shattered idea that US was exiting the Middle East

      December 24, 2025
    • Trump trade crackdown hits cheap food containers from China, Vietnam with massive new duties

      December 24, 2025
    • Epstein file drop includes ‘untrue and sensationalist claims’ about Trump, DOJ says

      December 24, 2025
    • Lawmakers probe SBA loans linked to Minnesota’s $9B fraud scandal: ‘Reckless decision making’

      December 24, 2025
    • Senate quietly works on bipartisan Obamacare fix as healthcare cliff nears

      December 24, 2025

    Categories

    • Business (1,144)
    • Investing (3,759)
    • Politics (4,560)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved